Clark Hill: Fifth Circuit Upholds FDA GLP-1 Shortage Decisions, Narrowing Path for Mass-Market Compounding
September 11, 2026
September 11, 2026
BIRMINGHAM, Michigan, Sept. 11 -- Clark Hill, a law firm, issued the following legal update:
* * *
Fifth Circuit Upholds FDA GLP-1 Shortage Decisions, Narrowing Path for Mass-Market Compounding
Author: Jose Vela Jr.
Two appellate decisions involving semaglutide and tirzepatide uphold the FDA's determinations that the shortages of Ozempic, Wegovy, Mounjaro, and Zepbound have ended and limit continued reliance on the shortage exception for c . . .
* * *
Fifth Circuit Upholds FDA GLP-1 Shortage Decisions, Narrowing Path for Mass-Market Compounding
Author: Jose Vela Jr.
Two appellate decisions involving semaglutide and tirzepatide uphold the FDA's determinations that the shortages of Ozempic, Wegovy, Mounjaro, and Zepbound have ended and limit continued reliance on the shortage exception for c . . .